Shingles Vaccines Now Available For 18+ People With Weak Immune Systems - How Long Does The Vaccine Last?

Updated Aug 29, 2025 | 02:50 PM IST

SummaryVaccinations are one of the most necessary parts of healthcare and have played an important role in ensuring that we can avoid health issues. As such, UK is making some changes to their shingles vaccine eligibility.
Shingles Vaccines Now Available For 18+ People With Weak Immune Systems - How Long Does The Vaccine Last?

(Credit-Canva)

Starting on September 1, 2025, the NHS in the UK is expanding who can get the shingles vaccine. The program now includes all adults aged 18 and older who have a very weak immune system. This change aims to protect about 300,000 more people from the painful and serious problems shingles can cause.

This decision came from a group of experts called the Joint Committee on Vaccination and Immunisation (JCVI). They found that younger adults with weak immune systems face a similar risk of getting so sick from shingles that they need to go to the hospital, just like older adults who were already getting the vaccine.

Dr. Amanda Doyle from NHS England says the vaccine is safe and works well. She explains that it greatly lowers the chance of getting shingles and becoming seriously ill. She encourages anyone who is now eligible to get vaccinated as soon as possible, even if they have had shingles before, since you can get it more than once.

Who Is Now Eligible for Shingles Vaccine?

Shingles is caused by the same virus as chickenpox, and it can cause a very painful rash. For most people, it's not a serious illness, but it can lead to problems like long-lasting nerve pain, eye issues, or even more serious infections like pneumonia.

The new group of people who can get the vaccine includes those with conditions like leukemia or lymphoma, or those going through chemotherapy. These individuals are at a much higher risk of getting very sick if they get shingles. The NHS will start contacting eligible patients soon, but you can also book an appointment through your doctor's office.

How Long Does Shingles Vaccine Work?

According to the Harvard Health, the Center of Disease Control and Prevention recommends that adults aged 50 and older get two doses of the Shingrix vaccine to prevent shingles. A 2024 study by Annals of Internal Medicine, looked at how well this vaccine works over time, and the results are very promising.

The study, which included almost two million people, found that the two-dose vaccine was still 73% effective at preventing shingles four years later. This shows that the vaccine provides long-lasting protection.

However, the study also highlighted the importance of getting both doses. People who only received one dose saw their protection drop quickly after the first year, with the vaccine being only 52% effective after three years. This makes it clear why getting the second shot is so important.

What If You're Late for the Second Shot?

If you miss the recommended two-to-six-month window for your second dose, don't worry—it's not too late. The study found that delaying the second dose beyond six months did not make the vaccine less effective. You should get your second dose as soon as you can to ensure you have full, long-lasting protection.

The study also found that the vaccine worked slightly better for people who got their shots before age 65 compared to those who were vaccinated later in life.

When Do You Need Shingles Shot?

Different countries have different guidelines, while CDC recommends people above 50 get vaccinated as well as adults aged 19 and older who have a weakened immune system should also get two doses to protect themselves.

In the UK, the shingles vaccine, called Shingrix, was previously given to people aged 65 to 79 and those with a very weak immune system who were 50 or older. However, following advice from a group of experts, this is changing.

Starting next week, all adults aged 18 and over with a very weak immune system will be able to get the vaccine. This is because the experts found that these younger adults face the same high risk of severe illness or long-lasting nerve pain from shingles as the groups who were already eligible.

End of Article

2 Dead, 21 Injured After Pennsylvania Nursing Home Catches Fire

Updated Dec 24, 2025 | 07:02 AM IST

SummaryA gas-related explosion triggered a fire at Silver Lake Nursing Home in Bristol Township, Pennsylvania. Governor Josh Shapiro confirmed two deaths and 21 injuries, with several residents rescued and five unaccounted for. Flames and debris were seen as crews responding to a gas odor shut off utilities during the incident Thursday.
2 Dead, 21 Injured After Pennsylvania Nursing Home Catches Fire

Source: Parkland Fire Company

A Pennsylvania nursing home caught on fire due to an apparent gas explosion. The Silver Lake Nursing home in Pennsylvania's Bristol Township caught on fire, and videos show flames erupting from the building, and debris scattered around the area. The Pennsylvania Governor Josh Shapiro confirmed the that there are so far two deaths, with 21 people found injured. Many have been rescued, yet rescuers believe that five people are unaccounted for.

What Happened At The Silver Lake Nursing Home?

At 2.15pm is when the flames could be seen from the gas-related explosion. PECO confirmed that crew had started to respond around 2pm itself after they received reports of a gas odor. The explosion had occurred when the crew were on the scene.

“While crews were on site, an explosion occurred at the facility. PECO crews shut off natural gas and electric service to the facility to ensure the safety of first responders and local residents,” the utility said in a the statement.

State Rep. Tina Davis told the Associated Press. "I saw smoke and I saw car after car after car was a fire truck or ambulance from all over the city, from all over."

Davis says that there were talks of using a nearby school as a temporary evacuation area.

Also Read: Birthday Celebrations Gone Wrong When A Hydrogen Balloon Exploded, Leaving The 33-year-Old Birthday Girl With First And Second Degree Burns

How Are Burn Injuries Treated?

Burn injuries are first classified before the treatment. Their classification decides the treatment the burn will require. There are for classifications of burns:

First-degree or superficial burns: They only affect the outer layer of the skin or the epidermis. In these injuries, the burn site is red, painful, dry, and has no blisters.

Second-degree or partial thickness burns: They are only the burns of epidermis and part of the lower layer of the skin, the dermis. The burn site looks red and blistered and may be swollen and painful.

Third-degree or full thickness burns: Third-degree burns destroy the epidermis and dermis. They could also go to the innermost later of the skin, the subcutaneous tissue. The burn site could look white or blackened and charred.

Fourth-degree burns: They burn through both layers of the skin and underlying tissue as well as deeper tissue, and could possibly reach muscle and bone. There is no feeling in the area since the nerve endings are destroyed.

The right way to treat a burn depends on its depth and how much of the body it covers. While minor, superficial burns can be managed at home, deeper or larger burns may need medical attention. Keep these essential guidelines in mind:

Do's:

  • Remove the source of the burn immediately – For example, take off clothing soaked in hot liquid to prevent further damage.
  • Run cool water over the burn – This helps soothe the skin, except in cases of certain chemical burns.
  • Keep the burn clean and protected – Cover it with a clean, non-stick bandage when possible.
  • Seek medical help – If the burn is deeper than a superficial layer, larger than your hand, or full-thickness, see a doctor.

Don’ts:

  • Use home remedies like bleach or butter – These can make the burn worse.
  • Apply ointments or creams on deep burns – They can trap heat and worsen the injury.
  • Put ice on the burn – It can cause more damage to the skin.
  • Pop blisters – This increases the risk of infection.

End of Article

Ben Sasse Diagnosed With Stage 4 Pancreatic Cancer: What We Know About His Diagnosis

Updated Dec 24, 2025 | 12:00 AM IST

SummaryFormer U.S. senator Ben Sasse has revealed a stage 4 pancreatic cancer diagnosis. Here’s what stage-four pancreatic cancer means, how it spreads, survival outlook, and how it compares with prostate cancer.
ben sasse cancer

Credits: Canva/AP

Former Senator Ben Sasse shared on Tuesday that he has been diagnosed with Stage 4 pancreatic cancer. The former two-term senator, now 53, revealed in a long social media message that he learned about the illness last week. “This is a hard note to write, but since many of you have already sensed something, I’ll get straight to it: Last week I was diagnosed with metastasized, stage-four pancreatic cancer, and I am going to die,” Sasse wrote. He went on to describe advanced pancreatic cancer as “brutal” and called it a death sentence, adding that mortality is something everyone carries.

“I’m fortunate to have incredible siblings and half a dozen friends who are truly like brothers to me. As one of them said, ‘Yes, you’re on the clock, but all of us are.’ Death is a cruel thief, and none of us escape it,” he added.

The Nebraska Republican also wrote, “I’ll have more to share. I’m not giving up without a fight.”

Ben Sasse Diagnosed With Stage 4 Cancer

Former senator and former University of Florida president Ben Sasse announced on Tuesday, Dec. 23, that he has been diagnosed with terminal stage 4 cancer, as per CNN News.

In the deeply personal message, the former Republican lawmaker from Nebraska described the diagnosis as a “death sentence,” while expressing appreciation for the steady support of his family and close friends.

Ben Sasse: What Happens In Stage 4 Pancreatic Cancer?

Stage 4 pancreatic cancer, also known as metastatic pancreatic cancer, means the disease has spread beyond the pancreas to distant organs such as the liver, lungs, or the lining of the abdomen. At this advanced stage, the cancer is generally considered incurable, and care focuses on prolonging life and easing symptoms like pain, weight loss, and jaundice through palliative treatment, with the goal of preserving quality of life, as per Cleveland Clinic.

Stage 4 Pancreatic Cancer: How Do Pancreatic And Prostate Cancer Survival Rates Compare?

Pancreatic cancer has a far poorer survival outlook than prostate cancer, largely because it is usually detected late and has fewer effective treatment options. Most men diagnosed with prostate cancer that has not spread survive at least five years, while pancreatic cancer is often found at an advanced stage, where long-term survival is uncommon.

According to the American Cancer Society, pancreatic cancer makes up about 3 percent of all cancers in the United States but accounts for roughly 8 percent of cancer-related deaths. Most patients are diagnosed at Stage 4, and the disease is widely regarded as largely incurable. Prostate cancer, by contrast, is the second most common cancer among men, and the majority of those diagnosed do not die from it. The five-year relative survival rate for non-metastasized prostate cancer is 97.9 percent, dropping to about 38 percent once it spreads. These figures highlight how early detection and effective treatment options make prostate cancer far more survivable than pancreatic cancer.

Recent news has included diagnoses such as Ben Sasse’s terminal pancreatic cancer, as well as public figures like John Eimen, who died from prostate cancer. These cases draw attention to the difficulty of detecting pancreatic cancer early, since there are few reliable screening tools before symptoms appear. Prostate cancer, in contrast, often progresses slowly, and with regular screening and multiple treatment options, many men live for decades after diagnosis.

Ben Sasse: What Treatment Options Is Ben Sasse Pursuing For Stage-Four Pancreatic Cancer?

While treatments including chemotherapy, radiation, and in rare situations surgery are available, stage-four pancreatic cancer is still considered largely incurable. The absence of effective early screening contributes to delayed diagnosis, and although a small number of patients, such as Ruth Bader Ginsburg, have lived longer following surgery, these cases are rare. Well-known individuals including Alex Trebek and Aretha Franklin also battled the disease, which remains one of the deadliest cancers in the United States.

End of Article

National Obesity Registry Launched To Address India’s Rising Obesity Crisis, Says Dr Jitendra Singh

Updated Dec 23, 2025 | 04:35 PM IST

Summary Union Minister Dr Jitendra Singh urges careful use of anti-obesity drugs at AOCO, launches National Obesity Registry, and highlights the need for evidence-based, long-term approaches to tackle India’s obesity crisis. Keep reading for details.
national obesity registry

Credits: Canva

Union Minister of State (Independent Charge) for Science and Technology and Earth Sciences, along with responsibilities in the PMO, Personnel, Public Grievances, Pensions, Atomic Energy, and Space, Dr Jitendra Singh on Tuesday called for careful and evidence-led use of anti-obesity and weight-reduction medicines. He stressed that these drugs should be prescribed thoughtfully and not treated as routine or easy solutions.

Addressing the inaugural session of the Asia Oceania Conference on Obesity (AOCO), the minister said obesity is a complex, long-term condition that tends to recur and cannot be managed through isolated medical treatment alone. Instead, he said, it needs a wider response involving society at large.

At the same event, Dr Singh also launched the National Obesity Registry, describing it as an important step towards strengthening India’s obesity research framework. The initiative aims to support structured data collection, generate reliable evidence, and guide long-term policymaking in the area.

What Is National Obesity Registry?

During the conference, Dr Jitendra Singh formally unveiled the AIAARO Obesity Registry, calling it a major move to strengthen India’s research ecosystem. The registry will focus on systematic data collection, long-term follow-up, and evidence-based policymaking. It is expected to help improve clinical understanding of obesity and support the development of national strategies for its management.

India’s National Obesity Registry (NOR), launched in December 2025, is designed to create a strong and reliable data base on obesity trends across the country. This data will support public health policies, research efforts, and targeted interventions to address the growing obesity burden. The initiative is particularly significant for India, given its unique challenges related to metabolic obesity and its strong links with non-communicable diseases.

While launching the registry, Dr Singh also highlighted the strong focus placed by Prime Minister Narendra Modi on tackling lifestyle-related illnesses. He noted that the Prime Minister has repeatedly spoken about obesity on national platforms, reflecting a clear shift towards preventive healthcare. This approach, he said, is supported by initiatives such as FIT India, Khelo India, and programmes that encourage small but lasting behavioural changes.

Obesity Cannot Be Treated with Shortcuts: Dr Jitendra Singh

The minister warned against the increasing commercialisation of obesity treatment and the spread of misinformation in this space. Referring to a PIB release, he said unscientific claims and so-called quick solutions often mislead people and divert attention from treatments backed by medical evidence.

India has seen a growing use of injectable obesity treatments such as Wegovy and Poviztra, both based on semaglutide, and Yurpeak, which uses tirzepatide. These once-weekly injections work by mimicking gut hormones that help regulate appetite and are marketed by companies like Novo Nordisk and Eli Lilly. However, doctors caution that these drugs are not miracle solutions and must be combined with proper diet and physical activity. There are also concerns about their overuse at a time when obesity rates continue to rise.

India And Obesity

According to the World Health Organisation, obesity was linked to 3.7 million deaths globally in 2024. If strong action is not taken, the number of people living with obesity is expected to double by 2030. Recently, the WHO released its first-ever guideline on the use of Glucagon-Like Peptide-1, or GLP-1, therapies for managing obesity as a chronic and relapsing condition.

“Obesity is a major global health challenge that WHO is committed to addressing by supporting countries and people worldwide to control it effectively and equitably. Our new guidance recognises that obesity is a chronic disease that can be treated with comprehensive and lifelong care,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus.

End of Article